Process / pipelineGrowth factor delivery
BMP Release
The bone morphogenetic protein (BMP) release assay measures the kinetics and amount of BMP elution from a biomaterial carrier over time. BMP-2, BMP-6, BMP-7, and BMP-9 are potent osteoinductive growth factors discovered by Marshall Urist in 1965 that trigger bone and cartilage formation. When loaded into scaffolds, hydrogels, or implants, BMPs must be released in a controlled manner to maximize biological effect while minimizing systemic exposure. The release assay quantifies how much BMP is present in the surrounding medium at defined timepoints, enabling optimization of carrier materials and release profiles for bone regeneration and fracture healing applications.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Urist, M. R. (1965). Bone: formation by autoinduction. Science, 150(3698), 893-899. DOI: 10.1126/science.150.3698.893 ↗
- Reddi, A. H. (2001). Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, gremlin, and chordin. Arthritis Research, 3(1), 1-5. DOI: 10.1186/ar142 ↗
- Garrison, K. R., Donell, S., Reuben, A., et al. (2010). Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the management of fractures of long bones: a systematic review. The Journal of Bone and Joint Surgery, 89(4), 477-490. DOI: 10.1302/0301-620X.89B4.18887 ↗